Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1007P is a genomic DNA sequence classified as a pseudogene of the U6 small nuclear RNA gene family. Small nuclear RNA U6 (snRNA U6) is an essential non-coding RNA that forms part of the spliceosome, where it catalyzes removal of introns from pre-mRNA during splicing[1][3]. However, pseudogenes—including RNU6-1007P—are nonfunctional DNA sequences derived from once-functional genes through mutation, retrotransposition, or duplication events in evolution[4][5]. These U6-derived pseudogenes are neither transcribed into functional snRNA nor participate in RNA splicing or any other biological pathway, and thus have no recognized physiological, pathological, or drug target role. The human genome hosts many U6 snRNA pseudogenes, reflecting the evolutionary importance of the functional U6 snRNA but not conferring function to the pseudogene copies[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1007, pseudogene (RNU6-1007P).